BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 3262657)

  • 1. IL-4 bypasses the immune suppressive effect of cyclosporin A during the in vitro induction of murine cytotoxic T lymphocytes.
    Heeg K; Gillis S; Wagner H
    J Immunol; 1988 Oct; 141(7):2330-4. PubMed ID: 3262657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy between interleukin 4 and interleukin 2 conveys resistance to cyclosporin A during primary in vitro activation of murine CD8 cytotoxic T cell precursors.
    Bubeck R; Miethke T; Heeg K; Wagner H
    Eur J Immunol; 1989 Apr; 19(4):625-30. PubMed ID: 2499483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway.
    Pereira GM; Miller JF; Shevach EM
    J Immunol; 1990 Mar; 144(6):2109-16. PubMed ID: 1968924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC; Lancki DW; Moldwin RL; Fitch FW
    J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor promoters in conjunction with calcium ionophores mimic antigenic stimulation by reactivation of alloantigen-primed murine T lymphocytes.
    Isakov N; Altman A
    J Immunol; 1985 Dec; 135(6):3674-80. PubMed ID: 2999231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of precytotoxic T cells in cyclosporine-suppressed mixed lymphocyte reactions.
    Hooton JW; Miller CL; Helgason CD; Bleackley RC; Gillis S; Paetkau V
    J Immunol; 1990 Feb; 144(3):816-23. PubMed ID: 2136900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytotoxic T lymphocytes. II. Frequency analysis of cyclosporin A-sensitive alloreactive cytotoxic T-lymphocyte precursors.
    Kabelitz D; Zanker B; Zanker C; Heeg K; Wagner H
    Immunology; 1987 May; 61(1):57-62. PubMed ID: 3108142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes.
    Mehrotra PT; Wu D; Crim JA; Mostowski HS; Siegel JP
    J Immunol; 1993 Sep; 151(5):2444-52. PubMed ID: 8103066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, augments cyclosporin A inhibition of cytolytic T lymphocyte induction.
    Bowlin TL; Rosenberger AL; McKown BJ
    Clin Exp Immunol; 1989 Jul; 77(1):151-6. PubMed ID: 2504519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine blocks the activation of antigen-dependent cytotoxic T lymphocytes directly by an IL-2-independent mechanism.
    Havele C; Paetkau V
    J Immunol; 1988 May; 140(10):3303-8. PubMed ID: 2966195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-2 and IL-4 can co-modulate the generation of cytotoxic T cells through CD8- CD4- splenic lymphocytes.
    Good MF; Powell LW; Halliday JW
    Immunology; 1989 Jun; 67(2):225-30. PubMed ID: 2568977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of human alloantigen-reactive T lymphocytes. III. Evidence that cyclosporine has an inhibitory effect on human CTL and CTL precursors, independent of CsA-mediated helper T cell dysfunction.
    Orosz CG; Adams PW; Ferguson RM
    Transplantation; 1988 Aug; 46(2 Suppl):73S-79S. PubMed ID: 2970141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
    Makrigiannis AP; Hoskin DW
    J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells.
    Okada M; Kitahara M; Kishimoto S; Matsuda T; Hirano T; Kishimoto T
    J Immunol; 1988 Sep; 141(5):1543-9. PubMed ID: 3261754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
    Sawada S; Suzuki G; Kawase Y; Takaku F
    J Immunol; 1987 Sep; 139(6):1797-803. PubMed ID: 2442255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of cloned T cell function. I. Dissection of cloned T cell proliferative responses using cyclosporin A.
    Orosz CG; Fidelus RK; Roopenian DC; Widmer MB; Ferguson RM; Bach FH
    J Immunol; 1982 Nov; 129(5):1865-8. PubMed ID: 6214580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloantigen-specific suppressor T cells are not inhibited by cyclosporin A, but do require IL 2 for activation.
    Bucy RP
    J Immunol; 1986 Aug; 137(3):809-13. PubMed ID: 2424984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of interleukin 2 on the immunosuppressive action of cyclosporine.
    Hess AD
    Transplantation; 1985 Jan; 39(1):62-8. PubMed ID: 3155579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines.
    Orosz CG; Zinn NE; Olsen RG; Mathes LE
    J Immunol; 1985 May; 134(5):3396-403. PubMed ID: 2984289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.